Tracy Davyduke, Puneeta Tandon, Mustafa Al‐Karaghouli, Juan G. Abraldes, Mang M. Ma – 29 July 2019 – Detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is essential for stratifying patients according to the risk of liver‐related morbidity. Noninvasive methods such as vibration‐controlled transient elastography (VCTE) and Fibrosis‐4 index (FIB‐4) have been recommended to identify patients for further assessment. The aim of this study was to assess the potential impact of implementing a “FIB‐4 First” strategy to triage patients entering a NAFLD assessment pathway.

Michael H. Le, Yee Hui Yeo, Linda Henry, Mindie H. Nguyen – 29 July 2019 – There is growing evidence that links nonalcoholic fatty liver disease (NAFLD) with impairment of renal function. As such, we aimed to demonstrate the trend of NAFLD, NAFLD with renal insufficiency (RI), disease awareness, and mortality over time. Patient data were extracted from the National Health and Nutrition Examination Survey (NHANES) 1999‐2016. A total of 14,255 adult study participants without competing liver disease or heavy drinking and with complete laboratory data were included.

Matthew P. Wallen, Shelley E. Keating, Adrian Hall, Ingrid J. Hickman, Toby G. Pavey, Aidan J. Woodward, Tina L. Skinner, Graeme A. Macdonald, Jeff S. Coombes – 29 July 2019

George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou – 29 July 2019

Sungwoo Choi, Bingning Dong, Chih‐Chun Janet Lin, Mi Jeong Heo, Kang Ho Kim, Zhen Sun, Martin Wagner, Nagireddy Putluri, Jae Myoung Suh, Meng C. Wang, David D. Moore – 29 July 2019

Hyung‐Don Kim, Seongyeol Park, Seongju Jeong, Yong Joon Lee, Hoyoung Lee, Chang Gon Kim, Kyung Hwan Kim, Seung‐Mo Hong, Jung‐Yun Lee, Sunghoon Kim, Hong Kwan Kim, Byung Soh Min, Jong Hee Chang, Young Seok Ju, Eui‐Cheol Shin, Gi‐Won Song, Shin Hwang, Su‐Hyung Park – 28 July 2019

Jeong‐Moo Lee, Ahmed Shehta, Kyung‐Suk Suh, Suk Kyun Hong, Kyung Chul Yoon, Jae‐Hyung Cho, Nam‐Joon Yi, Kwang‐Woong Lee – 26 July 2019

In this webinar, Drs. Marlyn Mayo and Cynthia Levy will discuss the most important recommendations included in the 2018 PBC Practice Guidance document. We will utilize a prerecorded webinar format for on-demand viewing on Liver Learning ® .Cynthia Levy Cynthia Levy, MD, FAASLD is a Professor of Medicine in the Division of Digestive Health and Liver Diseases and is the Associate Director of the Schiff Center for Liver Diseases at the University of Miami. She was awarded the Arthur Hertz Endowed Chair in Liver Diseases. Dr. Levy received her M.D.

Fang Luo, Rui Liao – 25 July 2019

Samarth S. Patel, Viviana A. Rodriguez, Mohammad B. Siddiqui, Masoud Faridnia, Fei‐Pi Lin, Anchalia Chandrakumaran, John Laurenzano, Joseph Clinton, Gurukripa N. Kowlgi, Danielle Kirkman, Adam P. Sima, Erika Liptrap, Chandra Bhati, Mohammad Shadab Siddiqui – 25 July 2019 – Cardiovascular disease (CVD) is a major contributor to longterm mortality after liver transplantation (LT) necessitating aggressive modification of CVD risk.